BAJAJHCARENSEBajaj Healthcare Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 2 Apr, 2025 · 17:13 IST

Bajaj Healthcare Limited has informed the Exchange regarding Resignation of Dayashankar Patel as Chief Financial Officer of the company w.e.f. April 15, 2025.

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹667.25
prior close
₹661.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-1.1% vs market
Pharmaceuticals peers, median of 147sector+2.3%-2.4% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+4.7
10m
+5.8
15m
+4.8
30m
+4.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0+1.0-1.1+2.3-2.4
Next day
-11.3-2.6-8.6-0.6-10.7
2d
-14.6-6.9-7.7-4.6-9.9
3d
-13.0-4.6-8.4-3.1-10.0
4d
-15.8-5.8-10.0-4.0-11.9
5d
-12.8-2.6-10.2-1.9-10.9
1w
-7.1+1.4-8.4+1.0-8.0
15d
-16.4+2.0-18.4+2.3-18.6
1m
-22.1+1.2-23.3+1.3-23.4
2m
-21.1+11.7-32.8+6.4-27.5
3m
-26.9+15.2-42.1+7.2-34.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bajaj Healthcare Limited has informed the stock exchanges that Mr. Dayashankar Patel has resigned as the Chief Financial Officer of the company, effective April 15, 2025. The company has not disclosed the specific reason for his resignation in this filing. As the CFO is a Key Managerial Personnel (KMP) under SEBI regulations, any change requires mandatory disclosure to the exchanges. No information about a successor or interim CFO arrangement has been mentioned in the announcement.

Likely market impact

A CFO resignation, especially without immediate clarity on succession, may create short-term uncertainty among investors and could affect investor confidence. The stock may see some volatility until the company announces a replacement.